Publication: Incidence, clinical, risk factors and outcomes of Guillain-Barré in Covid-19.
| dc.contributor.author | Fragiel, Marcos | |
| dc.contributor.author | Miro, Oscar | |
| dc.contributor.author | Llorens, Pere | |
| dc.contributor.author | Jimenez, Sonia | |
| dc.contributor.author | Piñera, Pascual | |
| dc.contributor.author | Burillo, Guillermo | |
| dc.contributor.author | Martin, Alfonso | |
| dc.contributor.author | Martin-Sanchez, Francisco J | |
| dc.contributor.author | Garcia-Lamberechts, Eric J | |
| dc.contributor.author | Jacob, Javier | |
| dc.contributor.author | Alquezar-Arbe, Aitor | |
| dc.contributor.author | Juarez, Ricardo | |
| dc.contributor.author | Jimenez, Blas | |
| dc.contributor.author | Del Rio, Rigoberto | |
| dc.contributor.author | Mateo Roca, Miriam | |
| dc.contributor.author | Garcia, Arturo H | |
| dc.contributor.author | Lopez Laguna, Nieves | |
| dc.contributor.author | Lopez Diez, Maria P | |
| dc.contributor.author | Pedraza Garcia, Jorge | |
| dc.contributor.author | Fernandez de Simon Almela, Amparo | |
| dc.contributor.author | Lopez Diaz, Juan J | |
| dc.contributor.author | Eiroa Hernandez, Patricia | |
| dc.contributor.author | Ruiz de Lobera, Noemi | |
| dc.contributor.author | Porta-Etessam, Jesus | |
| dc.contributor.author | Fernandez Perez, Cristina | |
| dc.contributor.author | Calvo, Elpidio | |
| dc.contributor.author | Gonzalez Del Castillo, Juan | |
| dc.contributor.group | SIESTA (Spanish Investigators in Emergency Situations Team) network | |
| dc.date.accessioned | 2023-02-09T10:38:09Z | |
| dc.date.available | 2023-02-09T10:38:09Z | |
| dc.date.issued | 2020-12-09 | |
| dc.description.abstract | We diagnosed 11 Guillain-Barré syndrome (GBS) cases among 71,904 COVID patients attended at 61 Spanish emergency departments (EDs) during the 2-month pandemic peak. The relative frequency of GBS among ED patients was higher in COVID (0.15‰) than non-COVID (0.02‰) patients (odds ratio [OR] = 6.30, 95% confidence interval [CI] = 3.18-12.5), as was the standardized incidence (9.44 and 0.69 cases/100,000 inhabitant-years, respectively, OR = 13.5, 95% CI = 9.87-18.4). Regarding clinical characteristics, olfactory-gustatory disorders were more frequent in COVID-GBS than non-COVID-GBS (OR = 27.59, 95% CI = 1.296-587) and COVID-non-GBS (OR = 7.875, 95% CI = 1.587-39.09) patients. Although COVID-GBS patients were more frequently admitted to intensive care, mortality was not increased versus control groups. Our results suggest SARS-CoV-2 could be another viral infection causing GBS. ANN NEUROL 2021;89:598-603. | |
| dc.description.version | Si | |
| dc.identifier.citation | Fragiel M, Miró Ò, Llorens P, Jiménez S, Piñera P, Burillo G, et al. Incidence, clinical, risk factors and outcomes of Guillain-Barré in Covid-19. Ann Neurol. 2021 Mar;89(3):598-603. | |
| dc.identifier.doi | 10.1002/ana.25987 | |
| dc.identifier.essn | 1531-8249 | |
| dc.identifier.pmid | 33295021 | |
| dc.identifier.uri | http://hdl.handle.net/10668/16761 | |
| dc.issue.number | 3 | |
| dc.journal.title | Annals of neurology | |
| dc.journal.titleabbreviation | Ann Neurol | |
| dc.language.iso | en | |
| dc.organization | IMIBIC | |
| dc.page.number | 598-603 | |
| dc.provenance | Realizada la curación de contenido 26/07/2024 | |
| dc.publisher | John Wiley & Sons, Inc. | |
| dc.pubmedtype | Journal Article | |
| dc.relation.publisherversion | https://doi.org/10.1002/ana.25987 | |
| dc.rights.accessRights | Restricted Access | |
| dc.subject | Adult | |
| dc.subject | Aged | |
| dc.subject | COVID-19 | |
| dc.subject | Case-Control Studies | |
| dc.subject | Female | |
| dc.subject | Guillain-Barre Syndrome | |
| dc.subject | Hospital Mortality | |
| dc.subject | Humans | |
| dc.subject.decs | España | |
| dc.subject.decs | Factores inmunológicos | |
| dc.subject.decs | Factores de riesgo | |
| dc.subject.decs | Incidencia | |
| dc.subject.decs | Inmunoglobulinas intravenosas | |
| dc.subject.decs | Masculino | |
| dc.subject.decs | Tiempo de internación | |
| dc.subject.decs | Trastornos del gusto | |
| dc.subject.decs | Trastornos del olfato | |
| dc.subject.decs | Unidades de cuidados intensivos | |
| dc.subject.mesh | Immunoglobulins, Intravenous | |
| dc.subject.mesh | Immunologic Factors | |
| dc.subject.mesh | Incidence | |
| dc.subject.mesh | Intensive Care Units | |
| dc.subject.mesh | Length of Stay | |
| dc.subject.mesh | Male | |
| dc.subject.mesh | Middle Aged | |
| dc.subject.mesh | Olfaction Disorders | |
| dc.subject.mesh | Risk Factors | |
| dc.subject.mesh | SARS-CoV-2 | |
| dc.subject.mesh | Spain | |
| dc.subject.mesh | Taste Disorders | |
| dc.title | Incidence, clinical, risk factors and outcomes of Guillain-Barré in Covid-19. | |
| dc.type | research article | |
| dc.volume.number | 89 | |
| dspace.entity.type | Publication |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- RISalud_Accesorestringido.pdf
- Size:
- 93.39 KB
- Format:
- Adobe Portable Document Format

